The Manufacturers Life Insurance Company lifted its position in eMagin Corporation (NYSE:EMA – Free Report) by 6.1% in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,232,687 shares of the company’s stock after acquiring an additional 71,020 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in eMagin were worth $65,258,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. State of Tennessee Department of Treasury purchased a new position in shares of eMagin during the second quarter valued at $7,749,000. Russell Investments Group Ltd. boosted its position in eMagin by 26.7% during the 3rd quarter. Russell Investments Group Ltd. now owns 107,611 shares of the company’s stock worth $5,164,000 after acquiring an additional 22,654 shares during the period. EverSource Wealth Advisors LLC boosted its position in eMagin by 1,375.0% during the 4th quarter. EverSource Wealth Advisors LLC now owns 708 shares of the company’s stock worth $35,000 after acquiring an additional 660 shares during the period. Venturi Wealth Management LLC grew its stake in eMagin by 12.1% during the 1st quarter. Venturi Wealth Management LLC now owns 8,111 shares of the company’s stock valued at $421,000 after acquiring an additional 877 shares in the last quarter. Finally, DGS Capital Management LLC purchased a new position in eMagin during the 1st quarter valued at about $349,000.
Wall Street Analyst Weigh In
A number of analysts have recently issued reports on the stock. Barclays reduced their price target on shares of eMagin from $55.00 to $53.00 and set an “equal weight” rating for the company in a research report on Monday, August 10th. Weiss Ratings raised shares of eMagin from a “buy (b-)” rating to a “buy (b)” rating in a research report on Wednesday. One research analyst has rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, eMagin has an average rating of “Hold” and a consensus price target of $53.00.
eMagin Stock Performance
eMagin stock opened at $49.18 on Friday. The firm’s fifty day simple moving average is $52.08 and its 200-day simple moving average is $52.22. eMagin Corporation has a 1-year low of $45.77 and a 1-year high of $55.49.
eMagin Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Monday, August 17th. Shareholders of record on Monday, August 3rd were given a dividend of $0.7325 per share. This represents a $2.93 annualized dividend and a yield of 6.0%. The ex-dividend date of this dividend was Monday, August 3rd.
eMagin Company Profile
eMagin Corporation engages in the design, develop, manufacture, and market of organic light-emitting diode (OLED) miniature displays on-silicon micro displays, virtual imaging products that utilize OLED micro displays, and related products in the United States and internationally. It offers super video graphics array (SVGA) + OLED micro displays; digital SVGA OLED-XL; super extended graphics array OLED-XL/XLS; video graphics array OLED-XL; and widescreen ultra-extended graphics array OLED-XL. The company also provides design reference kits, which include a micro display and associated electronics to help original equipment manufacturers (OEMs) to evaluate micro display products; near-eye virtual imaging modules that incorporate its OLED-on-silicon micro displays with its lenses and electronic interfaces for integration into OEM products; prism optics, a molded plastic prism lens that permits its AMOLED micro displays to provide realistic images that can be viewed for extended periods with reduced eye-fatigue; and driver boards.
Further Reading
- Five stocks we like better than eMagin
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Want to see what other hedge funds are holding EMA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for eMagin Corporation (NYSE:EMA – Free Report).
Receive News & Ratings for eMagin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for eMagin and related companies with MarketBeat.com's FREE daily email newsletter.
